Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
$10M to $50M
Last funding date
"Using CyberLeads, we closed a $54,000/year client. That's 35,600% ROI."
Andrew Miller - Co-Founder & CEO WordSmiths, Inc
Booked calls in your calendar with companies that just raised millions and are looking to outsource.